Monitoring asthma therapy using indirect bronchial provocation tests*
- 14 May 2007
- journal article
- review article
- Published by Wiley in The Clinical Respiratory Journal
- Vol. 1 (1) , 3-15
Abstract
Objectives: Bronchial provocation tests that assess airway hyperresponsiveness (AHR) are known to be useful in assisting the diagnosis of asthma and in monitoring inhaled corticosteroid therapy. We reviewed the use of bronchial provocation tests that use stimuli that act indirectly for monitoring the benefits of inhaled corticosteroids.Data Source: Published clinical trials investigating the effect of inhaled corticosteroids on bronchial hyperresponsiveness in persons with asthma were used for this review.Study Selection: Studies using indirect stimuli to provoke airway narrowing such as exercise, eucapnic voluntary hyperventilation, cold air hyperventilation, hypertonic saline, mannitol, or adenosine monophosphate (AMP) to assess the effect of inhaled corticosteroids were selected.Results: Stimuli acting indirectly result in the release of a variety of bronchoconstricting mediators such as leukotrienes, prostaglandins, and histamine, from cells such as mast cells and eosinophils. A positive response to indirect stimuli is suggestive of active inflammation and AHR that is consistent with a diagnosis of asthma. Persons with a positive response to indirect stimuli benefit from daily treatment with inhaled corticosteroids. Symptoms and lung function are not useful to predict the long‐term success of inhaled corticosteroid dose as they usually resolve rapidly, and well before inflammation and AHR has resolved. Following treatment, AHR to indirect stimuli is attenuated. Further, during long‐term treatment, asthmatics can become as non‐responsive as non‐asthmatic healthy persons, suggesting that asthma is not active.Conclusions: Non‐responsiveness to indirect bronchial provocation tests following inhaled corticosteroids occurs weeks to months following the resolution of symptoms and lung function. Non‐responsiveness to indirect stimuli may provide a goal for adequate therapy with inhaled corticosteroids.Please cite this paper as: Brannan JD, Koskela H and Anderson SD. Monitoring asthma therapy using indirect bronchial provocation tests. The Clinical Respiratory Journal 2007;1:3–15.Keywords
This publication has 102 references indexed in Scilit:
- Asthma end points and outcomes: What have we learned?Journal of Allergy and Clinical Immunology, 2006
- Exhaled nitric oxide measurements: clinical application and interpretationThorax, 2006
- Asthma, COPD and bronchitis are just components of airway diseaseEuropean Respiratory Journal, 2006
- Dose-response comparison of budesonide dry powder inhalers using adenosine monophosphate bronchial challengeAnnals of Allergy, Asthma & Immunology, 2005
- Clinical efficacy of low-dose inhaled budesonide once or twice daily in children with mild asthma not previously treated with steroidsEuropean Respiratory Journal, 1998
- Airway Responsiveness in Asthma: Bronchial Challenge with Histamine and 4.5% Sodium Chloride Before and Afte BudesonideAllergy and Asthma Proceedings, 1997
- Budesonide treatment of moderate and severe asthma in children: A dose-response studyJournal of Allergy and Clinical Immunology, 1995
- A research method to induce and examine a mild exacerbation of asthma by withdrawal of inhaled corticosteroidClinical & Experimental Allergy, 1992
- Effect of inhaled budesonide on bronchial reactivity to histamine, exercise, and eucapnic dry air hyperventilation in patients with asthma.Thorax, 1991
- Effect of inhalation of corticosteroids on exercise induced asthma: randomised double blind crossover study of budesonide in asthmatic children.BMJ, 1985